SCHEDULE 13G

Company

RIGEL PHARMACEUTICALS INC

Filed

June 6, 2011

Accession Number

0000921895-11-001243

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →